Bladder Urothelial Carcinoma Clinical Trials

43 clinical trials for Bladder Urothelial Carcinoma across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer — RECRUITING · PHASE2
• Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB) — RECRUITING
• Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC — RECRUITING · PHASE1
• Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy — RECRUITING · PHASE2
• Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers — RECRUITING · PHASE1
• Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) — RECRUITING · PHASE3
• Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy — RECRUITING
• Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. — RECRUITING
• Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer — NOT_YET_RECRUITING · PHASE2
• Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer — NOT_YET_RECRUITING · PHASE2
• A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial — ACTIVE_NOT_RECRUITING · PHASE2
• Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers — COMPLETED · PHASE1
• Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial — WITHDRAWN · PHASE2
• Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors — TERMINATED · PHASE2
• Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer — NOT_YET_RECRUITING
• Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy — COMPLETED · PHASE1
• Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma — COMPLETED · PHASE2
• 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors — TERMINATED · PHASE2
• A Study of CDX-585 in Patients With Advanced Malignancies — COMPLETED · PHASE1
• Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer — COMPLETED · PHASE1
• Can VI-RADS/ADC Accurately Stage Bladder Cancer?? — ACTIVE_NOT_RECRUITING · NA
• Milademetan in Advanced/Metastatic Solid Tumors — TERMINATED · PHASE2
• ALDOA Expression in Bladder Urothelial Carcinoma — NOT_YET_RECRUITING
• Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer — NOT_YET_RECRUITING · PHASE2
• Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) — OTHER · NA
• A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies — COMPLETED · PHASE1
• A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma — COMPLETED · PHASE1
• Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer — TERMINATED · PHASE2
• A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies — COMPLETED · PHASE1
• Safety Analysis and Oncological Outcomes in HoLERT vs TURBT — OTHER · NA
• Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib — TERMINATED
• Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer — COMPLETED · PHASE1
• A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival — TERMINATED · PHASE1
• A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma — OTHER · PHASE4
• En Bloc TURBT With Collins Loop vs Conventional TURBT — OTHER · NA
• Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma — OTHER · PHASE2
• Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy — OTHER · NA
• Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC — OTHER · NA
• Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy — TERMINATED · PHASE1
• The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma — OTHER

Refine this search